• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Evaluation of TATI and other markers in solid tumors.

作者信息

Taccone W, Mazzon W, Belli M

机构信息

Analysis Laboratory, Civic Hopytal, USL 4, Avellino, Italy.

出版信息

Scand J Clin Lab Invest Suppl. 1991;207:25-32. doi: 10.3109/00365519109104622.

DOI:10.3109/00365519109104622
PMID:1780686
Abstract

The usefulness of tumor-associated trypsin inhibitor (TATI) in the diagnosis of various solid tumors was compared to other tumor markers occurring in serum and urine (CEA, CA19-9, CA125, CA72-4, CA50, CA15-3, CA72-4, NSE, TPA, AFP, CK-BB and ferritin). TATI was particularly well suited for the diagnosis of tumors of the pancreas, ovary, oesophagus and bladder. For tumors of these organs TATI may be considered the marker of choice. TATI was also a good marker for distinguishing between disease with or without liver metastasis in cancer of the colon and the breast.

摘要

相似文献

1
Evaluation of TATI and other markers in solid tumors.
Scand J Clin Lab Invest Suppl. 1991;207:25-32. doi: 10.3109/00365519109104622.
2
Tumor-associated trypsin inhibitor in pancreatic diseases.胰腺疾病中的肿瘤相关胰蛋白酶抑制剂
Scand J Clin Lab Invest Suppl. 1991;207:71-3. doi: 10.3109/00365519109104633.
3
Tumor-associated trypsin inhibitor (TATI) in benign and malignant gastric disease.良性和恶性胃部疾病中的肿瘤相关胰蛋白酶抑制剂（TATI）
Scand J Clin Lab Invest Suppl. 1991;207:59-62. doi: 10.3109/00365519109104629.
4
Tumor-associated trypsin inhibitor (TATI) in patients with colorectal carcinoma. A critical comparison with CEA.结直肠癌患者的肿瘤相关胰蛋白酶抑制剂（TATI）。与癌胚抗原（CEA）的关键比较。
Scand J Clin Lab Invest Suppl. 1991;207:43-6. doi: 10.3109/00365519109104625.
5
The concomitant determination of different serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow-up of patients.上皮性卵巢癌中不同血清肿瘤标志物的联合检测：对监测化疗反应及患者随访的意义
Gynecol Oncol. 1992 Feb;44(2):155-60. doi: 10.1016/0090-8258(92)90031-d.
6
Tumor-associated trypsin inhibitor, TATI, in gastrointestinal cancer and related benign diseases.肿瘤相关胰蛋白酶抑制剂（TATI）在胃肠道癌及相关良性疾病中的研究
Scand J Clin Lab Invest Suppl. 1991;207:67-9. doi: 10.3109/00365519109104632.
7
Postoperative CEA is a better prognostic marker than CA19-9, hCGβ or TATI after resection of colorectal liver metastases.结直肠肝转移瘤切除术后，术后癌胚抗原（CEA）是比糖类抗原19-9（CA19-9）、人绒毛膜促性腺激素β亚基（hCGβ）或组织多肽特异性抗原（TATI）更好的预后标志物。
Tumour Biol. 2018 Jan;40(1):1010428317752944. doi: 10.1177/1010428317752944.
8
TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.用于监测膀胱移行细胞癌的组织型纤溶酶原激活剂（TPA）、肿瘤相关组织激肽释放酶（TATI）、癌胚抗原（CEA）、甲胎蛋白（AFP）、β-人绒毛膜促性腺激素（β-HCG）、前列腺特异抗原（PSA）、鳞状细胞癌抗原（SCC）及癌抗原19-9（CA 19-9）
Am J Clin Oncol. 1996 Jun;19(3):271-7. doi: 10.1097/00000421-199606000-00013.
9
The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis.
Gynecol Oncol. 1992 Feb;44(2):147-54. doi: 10.1016/0090-8258(92)90030-m.
10
TATI (tumour-associated trypsin inhibitor) as a marker of ovarian cancer.肿瘤相关胰蛋白酶抑制剂（TATI）作为卵巢癌的标志物
Br J Cancer. 1995 May;71(5):1051-4. doi: 10.1038/bjc.1995.202.

引用本文的文献

1
SPINK1 facilitates tumor progression via the EGFR/JAK/STAT3 axis in oral squamous cell carcinoma: insights from single-cell RNA sequencing.SPINK1通过EGFR/JAK/STAT3轴促进口腔鳞状细胞癌的肿瘤进展：来自单细胞RNA测序的见解
Front Oncol. 2025 Aug 19;15:1585277. doi: 10.3389/fonc.2025.1585277. eCollection 2025.
2
SPINK1 immunohistochemistry: An ancillary tool to diagnose urothelial carcinoma in situ and urothelial dysplasia.丝氨酸蛋白酶抑制剂Kazal型1免疫组化：诊断原位尿路上皮癌和尿路上皮发育异常的辅助工具。
Pathol Res Pract. 2025 Sep;273:156148. doi: 10.1016/j.prp.2025.156148. Epub 2025 Jul 28.
3
Urinary Biomarkers for Detection of Clinical Endometriosis or Adenomyosis.
用于检测临床子宫内膜异位症或子宫腺肌病的尿液生物标志物。
Biomedicines. 2022 Apr 1;10(4):833. doi: 10.3390/biomedicines10040833.
4
Modulation of Gold Nanorod Growth via the Proteolysis of Dithiol Peptides for Enzymatic Biomarker Detection.通过二硫肽的蛋白水解作用来调节金纳米棒的生长，用于酶生物标志物检测。
ACS Appl Mater Interfaces. 2021 Sep 29;13(38):45236-45243. doi: 10.1021/acsami.1c11620. Epub 2021 Sep 14.
5
Tazarotene-Induced Gene 1 (TIG1) Interacts with Serine Protease Inhibitor Kazal-Type 2 (SPINK2) to Inhibit Cellular Invasion of Testicular Carcinoma Cells.Tazarotene 诱导基因 1（TIG1）与丝氨酸蛋白酶抑制剂 Kazal 型 2（SPINK2）相互作用，抑制睾丸癌细胞的细胞侵袭。
Biomed Res Int. 2019 Nov 25;2019:6171065. doi: 10.1155/2019/6171065. eCollection 2019.
6
Proteome analysis of sheep B lymphocytes in the course of bovine leukemia virus-induced leukemia.牛白血病病毒诱导的绵羊白血病病程中B淋巴细胞的蛋白质组分析
Exp Biol Med (Maywood). 2017 Jul;242(13):1363-1375. doi: 10.1177/1535370217705864. Epub 2017 Apr 24.
7
Serum tumor markers in pancreatic cancer-recent discoveries.血清肿瘤标志物在胰腺癌中的最新发现。
Cancers (Basel). 2010 Jun 2;2(2):1107-24. doi: 10.3390/cancers2021107.
8
Pancreatic secretory trypsin inhibitor: More than a trypsin inhibitor.胰腺分泌性胰蛋白酶抑制剂：不止是一种胰蛋白酶抑制剂。
World J Gastrointest Pathophysiol. 2010 Jun 15;1(2):85-90. doi: 10.4291/wjgp.v1.i2.85.
9
Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.血清肿瘤相关胰蛋白酶抑制剂水平升高可独立预测结直肠癌患者预后不良。
BMC Cancer. 2010 Sep 17;10:498. doi: 10.1186/1471-2407-10-498.
10
Identification of genes up-regulated in urothelial tumors: the 67-kd laminin receptor and tumor-associated trypsin inhibitor.尿路上皮肿瘤中上调基因的鉴定：67-kd层粘连蛋白受体和肿瘤相关胰蛋白酶抑制剂。
Am J Pathol. 2003 Aug;163(2):493-504. doi: 10.1016/S0002-9440(10)63678-4.